FDA Inspection 1180516 — CHRISTUS Health Shreveport-Bossier
The FDA completed an inspection of CHRISTUS Health Shreveport-Bossier on Aug 18, 2022 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 18, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shreveport, LA (United States)